Sinopharm COVID-19 vaccine-induced Stevens-Johnson syndrome.

Boualila, L; Mrini, B; Tagmouti, A; El Moubarik, N; Benchekroun Belabbes, M; Boutimzine, N; Cherkaoui, L O

Boualila, L; Mrini, B; Tagmouti, A; El Moubarik, N; Benchekroun Belabbes, M; Boutimzine, N; Cherkaoui, L O.

Afiliación

Boualila L; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco. Electronic address: l.boualila@um5s.net.ma.
Mrini B; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
Tagmouti A; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
El Moubarik N; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
Benchekroun Belabbes M; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
Boutimzine N; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.
Cherkaoui LO; Department of Ophtalmology A, Ibn-Sina Hospital, University of Med V, Rabat, Morocco.

J Fr Ophtalmol ; 45(4): e179-e182, 2022 04.

Article en En | MEDLINE | ID: mdl-35033375

Asunto(s)

COVID-19; Síndrome de Stevens-Johnson; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Humanos; Síndrome de Stevens-Johnson/diagnóstico; Síndrome de Stevens-Johnson/etiología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Síndrome de Stevens-Johnson / COVID-19 Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: J Fr Ophtalmol Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google